Abstract Session 6 – Epistaxis and HHT 1

Abstract Session 6 – Epistaxis and HHT 1

June 22, 2025 3:00 pm - June 22, 2025 4:15 pm
Sunday, June 22, 2025
Abstract Session 6 – Epistaxis and HHT 1
ROOM 13 (G15) | Level +1
15:00h -16:15h

ABSTRACTS
Chair 1: Annette Kjeldsen
Chair 2 : Florent Carsuzaa
4176 – One-Year Mortality and Morbidity of Epistaxis Compared to Controls in 1 789 Patients: Is Epistaxis Associated with Reduced Survival?
Radermecker François
4333 – Intranasal trigeminal and secretory function are impaired after topical anaesthesia or surgical treatment of epistaxis.
Soyka Michael
4389 – A quality improvement project to aim to assess and improve foundation doctor understanding and management of epistaxis
Brookes Thomas
4532 – A retrospective analysis of 12 years of epistaxis management at Department of ENT, University Hospital Centre Zagreb
Bilać Jakov
4213 – Pulsed dye laser treatment for epistaxis secondary to hereditary haemorrhagic telangiectasia: A comparison between the Epistaxis Severity Score and a novel simplified scoring system as patient-reported outcome measures
Bennett Stephen
4283 – Developing a Novel Patient Passport to Improve Emergency Management of Epistaxis in Hereditary Haemorrhagic Telangiectasia
Gera Ritika
4421 – Survival is shorter than expected in Hereditary hemorrhagic telangiectasia – results from a national population based register study.
Ahlstrom Emanuelsson Cecilia

Leave a comment

Your email address will not be published. Required fields are marked *

Event Information

June 22, 2025 3:00 pm - June 22, 2025 4:15 pm

Organizers

Location